Stryker (SYK) Asset Writedowns and Impairment (2010 - 2026)
Stryker (SYK) posted quarterly Asset Writedowns and Impairment of $1.0 million for Q2 2026, down 98.18% year-over-year from $55.0 million in Q2 2025, and down 85.71% on a QoQ basis from $7.0 million in Q4 2025.
Stryker (SYK) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Stryker has reported Asset Writedowns and Impairment for 11 years, with the latest figure at $1.0 million in Q2 2026.
- Asset Writedowns and Impairment for Q2 2026 came in at $1.0 million, down 98.18% year-over-year; the trailing twelve-month figure through Jun 2026 was $81.0 million (down 92.27% YoY), and the FY2025 annual result was $170.0 million, down 82.6% from the prior year.
- Asset Writedowns and Impairment declined to $1.0 million in Q2 2026, from $7.0 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $956.0 million in Q4 2024 and troughed at $1.0 million in Q2 2023.
- A 5-year average of $102.7 million and a median of $16.0 million in 2024 frame the typical range for Asset Writedowns and Impairment.
- The widest annual swing landed in 2024, when Asset Writedowns and Impairment surged 3883.33%; it then tumbled 99.27% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $252.0 million in 2022, then plunged by 90.48% to $24.0 million in 2023, then surged by 3883.33% to $956.0 million in 2024, then tumbled by 99.27% to $7.0 million in 2025, then tumbled by 85.71% to $1.0 million in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $1.0 million in Q2 2026, $7.0 million in Q4 2025, and $73.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Jun 30, 2026 | 1.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 55.00 Mn |
| Jun 30, 2025 | 55.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | 956.00 Mn |
| Dec 31, 2024 | 956.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 16.00 Mn |
| Jun 30, 2024 | 16.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 24.00 Mn |
| Dec 31, 2023 | 24.00 Mn |